Cardinal Health (CAH)
Cardinal Health R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CAH related companies
CAH News
Perception, Opportunity in Volatility - Research & Analysis on Cardinal Health, Inc. and Omnicare, Inc.
May 17, 9:00AM Marketwire
May 17, 9:00AM Marketwire
Listen to $CAH Cardinal Health, Inc. at Deutsche Bank AG Health Care Conference - live at 09:20 AM, ondemand after - http://stks.co/3hNj
about 21 days ago by earningscast
about 21 days ago by earningscast
UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract
May 04, 2:16PM Street Insider
May 04, 2:16PM Street Insider
$AMBN $CAH $KNSY $LNCR $STJ Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio
http://stks.co/3g9M
about 24 days ago by FASTgraphs
about 24 days ago by FASTgraphs
I think that 9% gain in the generics profit was probably the best number in the whole $CAH report.
about 24 days ago by bradloncar
about 24 days ago by bradloncar
Cardinal Health's CEO Discusses Q3 2012 Results - Earnings Call Transcript
May 03, 4:40PM Seeking Alpha
May 03, 4:40PM Seeking Alpha
Listen to $CAH Q3 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3e0n
about 25 days ago by earningscast
about 25 days ago by earningscast
Cardinal Health Raises Dividend for 24th Consecutive Year: http://stks.co/3d1I $CAH
about 26 days ago by DynamicDividend
about 26 days ago by DynamicDividend
These Companies Will Raise Their Dividends in May: http://stks.co/3bYZ $LOW $PEP $CAH $HNZ $CPK $BG $SWY $EXPD
about 27 days ago by DynamicDividend
about 27 days ago by DynamicDividend
This Healthcare Stock Seems a Bargain No Matter What the Supreme Court Says: Owen & Minor http://stks.co/36Im $OMI $MDT $JNJ $UNH $CAH
about 62 days ago by ycharts
about 62 days ago by ycharts
$CAH has no interest and gains nothing when oxycodone makes it to the street. That federal judge (and the DEA) should leave them alone.
about 88 days ago by bradloncar
about 88 days ago by bradloncar
$CAH 1 year default probability from Kamakura is 2 basis points. http://chart.ly/v6imyp2
about 102 days ago by KamakuraCo
about 102 days ago by KamakuraCo
Listen to $CAH Cardinal Health, Inc. at Leerink Swann Global Healthcare Conferen - live at 09:00 AM, ondemand after - http://stks.co/2RJC
about 102 days ago by earningscast
about 102 days ago by earningscast
$CAH Down Big with Earnings Today http://stks.co/2DEc #tradeideas #earnings #stocks #investing
about 116 days ago by TradeIdeas1
about 116 days ago by TradeIdeas1
Listen to $CAH Q2 2012 earnings call (EPS 0.81 vs est 0.76) - live at 08:30 AM, ondemand after - http://stks.co/2CyJ
about 116 days ago by earningscast
about 116 days ago by earningscast
$$ Cardinal Health raises 2012 profit forecast
http://stks.co/2CvN $CAH
about 116 days ago by stockspot
about 116 days ago by stockspot
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CAH | 41.67 | +0.20 | +0.48% | 14.40B |
| CAG | 25.25 | -0.01 | -0.04% | 10.42B |
| CAFI | 2.05 | -0.05 | -2.38% | 14.78M |
| CAF | 19.41 | -0.27 | -1.37% | |
| CAE | 9.85 | -0.02 | -0.20% | 2.541B |
| CADX | 2.72 | -0.08 | -2.86% | 232.61M |
| CADC | 1.68 | +0.00 | +0.00% | 29.94M |
| CACI | 43.65 | -0.27 | -0.61% | 1.156B |
| CACH | 4.72 | -0.20 | -4.07% | 60.65M |
| CACC | 87.78 | -1.28 | -1.44% | 2.249B |
